nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Consciousness abnormal—Thalidomide—leprosy	0.103	0.103	CcSEcCtD
Prochlorperazine—Parkinsonism—Thalidomide—leprosy	0.0394	0.0394	CcSEcCtD
Prochlorperazine—Altered state of consciousness—Thalidomide—leprosy	0.0388	0.0388	CcSEcCtD
Prochlorperazine—Embolism venous—Thalidomide—leprosy	0.0355	0.0355	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Thalidomide—leprosy	0.0295	0.0295	CcSEcCtD
Prochlorperazine—Galactorrhoea—Thalidomide—leprosy	0.0276	0.0276	CcSEcCtD
Prochlorperazine—Cyanosis—Thalidomide—leprosy	0.0253	0.0253	CcSEcCtD
Prochlorperazine—Cholestasis—Thalidomide—leprosy	0.0236	0.0236	CcSEcCtD
Prochlorperazine—Influenza—Dapsone—leprosy	0.022	0.022	CcSEcCtD
Prochlorperazine—Blood disorder—Thalidomide—leprosy	0.0215	0.0215	CcSEcCtD
Prochlorperazine—Apnoea—Thalidomide—leprosy	0.0211	0.0211	CcSEcCtD
Prochlorperazine—Amenorrhoea—Thalidomide—leprosy	0.0204	0.0204	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Thalidomide—leprosy	0.0204	0.0204	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Dapsone—leprosy	0.02	0.02	CcSEcCtD
Prochlorperazine—Dyskinesia—Thalidomide—leprosy	0.0191	0.0191	CcSEcCtD
Prochlorperazine—Gait disturbance—Thalidomide—leprosy	0.0184	0.0184	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Thalidomide—leprosy	0.0179	0.0179	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Thalidomide—leprosy	0.0179	0.0179	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Thalidomide—leprosy	0.0168	0.0168	CcSEcCtD
Prochlorperazine—Gynaecomastia—Thalidomide—leprosy	0.016	0.016	CcSEcCtD
Prochlorperazine—Erythema—Dapsone—leprosy	0.0153	0.0153	CcSEcCtD
Prochlorperazine—Photosensitivity—Thalidomide—leprosy	0.0148	0.0148	CcSEcCtD
Prochlorperazine—Eczema—Thalidomide—leprosy	0.0145	0.0145	CcSEcCtD
Prochlorperazine—Vision blurred—Dapsone—leprosy	0.0144	0.0144	CcSEcCtD
Prochlorperazine—Increased appetite—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Prochlorperazine—Cough—Dapsone—leprosy	0.0134	0.0134	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Thalidomide—leprosy	0.0133	0.0133	CcSEcCtD
Prochlorperazine—Cardiac arrest—Thalidomide—leprosy	0.0124	0.0124	CcSEcCtD
Prochlorperazine—Insomnia—Dapsone—leprosy	0.0113	0.0113	CcSEcCtD
Prochlorperazine—Influenza—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Prochlorperazine—Dysphagia—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Prochlorperazine—Eosinophilia—Thalidomide—leprosy	0.0111	0.0111	CcSEcCtD
Prochlorperazine—Pancytopenia—Thalidomide—leprosy	0.0107	0.0107	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Thalidomide—leprosy	0.0104	0.0104	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Thalidomide—leprosy	0.0103	0.0103	CcSEcCtD
Prochlorperazine—Weight increased—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Thalidomide—leprosy	0.0101	0.0101	CcSEcCtD
Prochlorperazine—Drowsiness—Thalidomide—leprosy	0.01	0.01	CcSEcCtD
Prochlorperazine—Body temperature increased—Dapsone—leprosy	0.00987	0.00987	CcSEcCtD
Prochlorperazine—Agranulocytosis—Thalidomide—leprosy	0.00935	0.00935	CcSEcCtD
Prochlorperazine—Oedema peripheral—Thalidomide—leprosy	0.00886	0.00886	CcSEcCtD
Prochlorperazine—Erythema multiforme—Thalidomide—leprosy	0.00851	0.00851	CcSEcCtD
Prochlorperazine—Arrhythmia—Thalidomide—leprosy	0.00804	0.00804	CcSEcCtD
Prochlorperazine—Headache—Dapsone—leprosy	0.00782	0.00782	CcSEcCtD
Prochlorperazine—Nervousness—Thalidomide—leprosy	0.00761	0.00761	CcSEcCtD
Prochlorperazine—Muscle spasms—Thalidomide—leprosy	0.00753	0.00753	CcSEcCtD
Prochlorperazine—Vision blurred—Thalidomide—leprosy	0.00738	0.00738	CcSEcCtD
Prochlorperazine—Tremor—Thalidomide—leprosy	0.00734	0.00734	CcSEcCtD
Prochlorperazine—Agitation—Thalidomide—leprosy	0.0072	0.0072	CcSEcCtD
Prochlorperazine—Angioedema—Thalidomide—leprosy	0.00716	0.00716	CcSEcCtD
Prochlorperazine—Leukopenia—Thalidomide—leprosy	0.00701	0.00701	CcSEcCtD
Prochlorperazine—Cough—Thalidomide—leprosy	0.00683	0.00683	CcSEcCtD
Prochlorperazine—Convulsion—Thalidomide—leprosy	0.00679	0.00679	CcSEcCtD
Prochlorperazine—Dry mouth—Thalidomide—leprosy	0.00652	0.00652	CcSEcCtD
Prochlorperazine—Oedema—Thalidomide—leprosy	0.00639	0.00639	CcSEcCtD
Prochlorperazine—Infection—Thalidomide—leprosy	0.00635	0.00635	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Thalidomide—leprosy	0.00626	0.00626	CcSEcCtD
Prochlorperazine—Skin disorder—Thalidomide—leprosy	0.00621	0.00621	CcSEcCtD
Prochlorperazine—Hypotension—Thalidomide—leprosy	0.00597	0.00597	CcSEcCtD
Prochlorperazine—Insomnia—Thalidomide—leprosy	0.00578	0.00578	CcSEcCtD
Prochlorperazine—Dyspnoea—Thalidomide—leprosy	0.0057	0.0057	CcSEcCtD
Prochlorperazine—Somnolence—Thalidomide—leprosy	0.00568	0.00568	CcSEcCtD
Prochlorperazine—Constipation—Thalidomide—leprosy	0.00547	0.00547	CcSEcCtD
Prochlorperazine—Urticaria—Thalidomide—leprosy	0.00508	0.00508	CcSEcCtD
Prochlorperazine—Body temperature increased—Thalidomide—leprosy	0.00505	0.00505	CcSEcCtD
Prochlorperazine—Hypersensitivity—Thalidomide—leprosy	0.00471	0.00471	CcSEcCtD
Prochlorperazine—Pruritus—Thalidomide—leprosy	0.00452	0.00452	CcSEcCtD
Prochlorperazine—Dizziness—Thalidomide—leprosy	0.00423	0.00423	CcSEcCtD
Prochlorperazine—Rash—Thalidomide—leprosy	0.00403	0.00403	CcSEcCtD
Prochlorperazine—Dermatitis—Thalidomide—leprosy	0.00403	0.00403	CcSEcCtD
Prochlorperazine—Headache—Thalidomide—leprosy	0.004	0.004	CcSEcCtD
